Chevron said on Wednesday that it plans to grow free cash flow by more than 10% annually through 2030 and increase oil and ...

Oregon Health & Science University leaders say a federal drug discount pilot set to begin next year could create a ...

Chevron (NYSE: CVX) used its investor day in New York to signal a confident long-term outlook, unveiling a five-year plan ...

Barrick Mining expanded its buyback program by $500 million and raised its dividend 25% after strong Q3 cash flow results.

Non-automotive growth -- Expanded commercial traction in off-road autonomy (e.g., Caterpillar, Forterra), aerospace (Lake ...

Get key Q3 2025 earnings insights for AdvanSix (ASIX), including CapEx cuts, cash flow strategies, risks, and sector outlook.

An Atlanta-based app founded by an immigrant entrepreneur is helping small business owners across the region operate more ...

Trailing Twelve-Month Core Product Sales -- $37 million, a company record, up from $33.8 million, with distributor and ...

Explore HighPeak Energy's Q3 2025 earnings insights—cost control, debt reduction, new CEO, and scenario-based strategy for 2026.

"What they found was that of all new drugs approved in the last 20 years, 12% came from the SBIR/STTR program," said Jere Glover.

At its investor day, Chevron Corporation (NYSE: CVX) outlined its five-year plan to 2030 and how it intends to deliver sustained cash flow growth, further strengthen its portfolio, advance power ...

Virgin Galactic reported Q3 results Thursday. A look at the key highlights and what's next for the space stock.